Melanie Eckersley-Maslin

6PUBLICATIONS
27CO-AUTHORS
Predictive and prognostic markersHaematological tumoursMedical molecular engineering of nucleic acids and proteinsElectrical circuits and systemsModels of care and place of birth
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 20, 2026
Embryonic stem cell factors DPPA2/4 amplify active H3K4me3-H2AK119ub chromatin domains in non-small cell lung cancer.

Janith A Seneviratne, Clare L Crisp, Eleanor Glancy

|Feb 22, 2024
Bivalent chromatin: a developmental balancing act tipped in cancer.

Eleanor Glancy, Natalie Choy, Melanie A Eckersley-Maslin

|Jan 12, 2023
Targeting Menin disrupts the KMT2A/B and polycomb balance to paradoxically activate bivalent genes.

Christina E Sparbier, Andrea Gillespie, Juliana Gomez

|Sep 16, 2022
Imprinting fidelity in mouse iPSCs depends on sex of donor cell and medium formulation.

Maria Arez, Melanie Eckersley-Maslin, Tajda Klobučar

|Dec 21, 2021
Maternal Dppa2 and Dppa4 are dispensable for zygotic genome activation but important for offspring survival.

Oana Kubinyecz, Fatima Santos, Deborah Drage

|Jan 30, 2019
Dppa2 and Dppa4 directly regulate the Dux-driven zygotic transcriptional program.

Mélanie Eckersley-Maslin, Celia Alda-Catalinas, Marloes Blotenburg

Pageof 1